Abstract
A series of novel compounds bearing a 3-(1H-indol-3-yl)pyrazole-5-carboxylic acid nucleus were synthesized. Analytical and spectral data confirmed the structures of the new compounds. The structures of the regioisomers in this series were determined by 1H-NMR spectra. The title compounds were evaluated for their endothelin-1 antagonist activities. In the in vitro functional assay, compounds 23, 24, 28 and 29 exhibited significant efficacy at the concentration of 1 μg/mL, and compounds 5b, 5c, 26 and 28 were as potent as the positive control bosentan at high concentration. In the experiment to assess prevention of endothelin-1-induced sudden death in mice, compound 5b showed comparable activity to bosentan, and 30 was more potent than bosentan. The final compounds were also screened for antibacterial activity against four Gram-positive and -negative bacteria. Some of the tested compounds showed weak antibacterial activity.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abdel-Aziz, M., Abuo-Rahma, G., El-Din. A., and Hassan, A. A., Synthesis of novel pyrazole derivatives and evaluation of their antidepressant and anticonvulsant activities. Eur. J. Med. Chem., 44, 3480–3487 (2009).
Akbas, E., Berber, I., Sener, A., and Hasanov, B., Synthesis and antibacterial activity of 4-benzoyl-1-methyl-5-phenyl-1H-pyrazole-3-carboxylic acid and derivatives. Farmaco, 60, 23–26 (2005).
Basavarajaiah, S. D. M. and Mruthyunjayaswamy, B. H. M., Synthesis and antimicrobial activity of some5-substituted-3-phenyl-Nβ-(substituted-2-oxo-2H-pyrano[2,3-b]quinoline-3-carbonyl)-1H-indole-2-carboxyhydrazide. Chem. Pharm. Bull., 57, 557–560 (2009).
Brady, T., Vu, K., Barber, J. R., Ng, S. C., and Zhou, Y. F., Synthesis of novel 2,3-substituted-2,4-dihydro-pyrazolo [4,3-d]pyrimidine-5,7-diones. Tetrahedron Lett., 50, 6223–6227 (2009).
Clozel, M., Breu, V., Gray, G. A., Kalina, B., Löffler, B. M., Burri, K., Cassal, J. M., Hirth, G., Müller, M., and Neidhart, W., Pharmacological characterization of Bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J. Pharmacol. Exp. Ther., 270, 228–235 (1994).
EI-Sabbagh, O. I., Baraka, M. M., Ibrahim, S. M., Pannecouque, C., Andrei, G., Snoeck, R., Balzarini, J., and Rashad, A. A., Synthesis and antiviral activity of new pyrazole and thiazole derivatives. Eur. J. Med. Chem., 44, 3746–3753 (2009).
Gorbunova, V. P. and Suvorov, N. N., Indoles derivatives LXXXIX. Synthesis of some diketo esters of the indole series and of indolypyrazoles from them. Khim. Geterotsikl. Soedin., 11, 1519–1522 (1973).
Ihara, M., Noguchi, K., Saeki, T., Fukuroda, T., Tsuchida, S., Kimura, S., Fukami, T., Ishikawa, K., Nishikibe, M., and Yano, M., Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci., 50, 247–255 (1992).
Jaiswal, N., Lambrecht, G., Mutschler, E., Tacke, R., and Malik, K. U., Pharmacological characterization of the vascular muscarinic receptors mediating relaxation and contraction in Rabbit Aorta. J. Pharmacol. Exp. Ther., 258, 842–850 (1991).
Jaronczyka, M., Dobrowolski, J. C., and Mazureka, A. P., Theoretical studies on tautomerism and IR spectra of pyrazole derivatives. J. Mol. Struct. (Theochem), 673, 17–28 (2004).
Karthikeyan, K., Veenus, S. T., Lalitha, K. G., and Perumal, P. T., Synthesis and antinociceptive activity of pyrazolyl isoxazolines and pyrazolyl isoxazoles. Bioorg. Med. Chem. Lett., 19, 3370–3373 (2009).
Okumura, H., Ashizawa, N., Aotsuka, T., Asakura, R., Kobayashi, F., and Matsuura, A., Possible mechanisms of sudden death and hemoconcentration induced by endothelin-1 and big endothelin-1 in mice. Biol. Pharm. Bull., 17, 645–650 (1994).
Okumura, H., Ashizawa, N., Asakura, R., Aotsuka, T., Kobayashi, F., and Matsuura, A., Possible involvement of different mechanisms in sudden death induced by endothelin-1 and big endothelin-1. Biol. Pharm. Bull., 18, 18–23 (1995).
Papesch, V. and Dodson, R. M., Isomeric pyrazolo[4,3-d]pyrimidinediones. J. Org. Chem., 30, 199–203 (1965).
Prasda, M. R. and Kishore, D. P., Multistep, microwave assisted, solvent free synthesis and antibacterial activity of 6-substituted-2,3,4-trihydropyrimido[1,2-c]9,10,11,12-tetrahydrobenzo[b]thieno[3,2-e] pyrimidines. Chem. Pharm. Bull., 55, 776–779 (2007).
Raschack, M., Unger, L., Riechers, H., and Klinge, D., Receptor selectivity of endothelin antagonists and prevention of vasoconstriction and endothelin-induced sudden death. J. Cardiovasc. Pharmacol., 26Suppl 3, S397–S399 (1995).
Rawson, D. J., Dack, K. N., Dickinson, R. P., and James, K., The design and synthesis of a novel series of indole derived selective ETA antagonists. Bioorg. Med. Chem. Lett., 12, 125–128 (2002).
Shawalil, A. S., Sherif, S. M., Darwish, M. A. A., and Elmerzabani, M. M., Synthesis and antitumor screening of new 1,7-diphenyl-3-(1,3-disubstituted-1H-pyrazole-4-carbonyl)-[1,2,4]triazolo[4,3-α] pyrimidin-5(1H)-ones. Arch. Pharm. Res., 33, 647–654 (2010).
Singh, N., Bhati, S. K., and Kumar, A., Thiazolyl/oxazolyl formazanyl indoles as potent anti-inflammatory agents. Eur. J. Med. Chem., 43, 2597–2609 (2008).
Yamamoto, Y. and Kurazono, M., A new class of anti-MRSA and anti-VRE agents: preparation and antibacterial activities of indole-containing compounds. Bioorg. Med. Chem. Lett., 17, 1626–1628 (2007).
Zhang, J., Didierlaurent, S., Fortin, M., Lefrancois, D., Uridata, E., and Veverta, J. P., Potent nonpeptide endothelin antagonists: Synthesis and structure-activity relationships of pyrazole-5-carboxylic acids. Bioorg. Med. Chem. Lett., 10, 2575–2578 (2000).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Zhang, D., Wang, G., Tan, C. et al. Synthesis and biological evaluation of 3-(1H-indol-3-yl)pyrazole-5-carboxylic acid derivatives. Arch. Pharm. Res. 34, 343–355 (2011). https://doi.org/10.1007/s12272-011-0301-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-011-0301-2